Medical Devices Today

U.S. Home Healthcare Products Market Report

 The combined U.S. market for home healthcare products reached $4.3 billion in 2007 and (despite current economic recession and uncertainty), is expected to expand at a compound annual growth rate of more than 4%, reaching nearly $5.2 billion in 2012. It is one of the largest and most stable in the United States (U.S.) due to the burgeoning aging population and corresponding increase in lifespan, the critical need for cost-effective medical equipment for patients suffering from long-term chronic conditions, and the increasing usage of technology by the baby-boomer population. Read more...

U.S. Diabetes Management Products Market Report

Diabetes affects nearly 24 million people in the U.S. and is the 5th leading cause of death by disease in the U.S. This costs the U.S. healthcare system more than $130 billion per year. To constrain spiraling healthcare costs, the development of more affordable and effective diabetes management (self-testing and treatment) products has become a top priority not only in the U.S., but worldwide. Diabetes management products have become one of the largest medical device and pharmaceutical markets in the U.S., totaling more than $15 billion. As the population of diabetics continues to increase, the market is expected to continue to grow at a double-digit rate over the next five years, reaching nearly $28 billion by 2013. Read on...

Airway Management & Ventilation Products (Europe)

Airway management and ventilation products are reportedly on track to become a $534 million market. Now you can understand it from every angle with this new report from Medtech Insight, the leading and most trusted provider of off-the-shelf medical technology market reports available today.

Oncology Outlook: How Cutting-Edge Medical Technology Is Improving the Odds for Cancer Patients

Elsevier Business Intelligence announces the publication of a new Special Report:

Oncology Outlook:
How Cutting-Edge Medical Technology Is
Improving the Odds for Cancer Patients

Fulfilling the Promise of the Scarless Surgery Revolution

 

"Fulfilling the Promise of the Scarless Surgery Revolution" Special Report published by Elsevier Business Intelligence.

When will breakthrough endoscopic technologies hit prime time?
Originally published in Medtech Insight: Medical Technology Market Intelligence®

Find out how you can get this report for FREE

Wound closure products sales are expected to grow 3.5% (CAGR),reaching over $4 billion by 2013. Get the facts!

 In 2008, more than 100 million wounds were treated in U.S. hospitals – these included surgical wounds; traumatic wounds; pressure, arterial, venous, and diabetic ulcers; burns; and amputations. In the same year, treatment of these wounds generated nearly $3.5 billion in wound closure product sales. Between 2008 and 2013, sales of traditional and emerging wound closure products are expected to increase at a compound annual growth rate of 3.5%, reaching over $4 billion by 2013… [Learn More about Report A124]

Surgical procedures involving same-day or less-invasive surgery are increasing in the USA. Find out why…

The number of surgical procedures performed in the United States (U.S.) is increasing, particularly those involving same-day/less-invasive surgery, and other technological advances are helping decrease a patient’s recovery time and hospital length of stay. For example, non-surgical cosmetic procedures are increasing, and in some cases, competing with traditional surgery – the recent growth in refractive surgery may be short-lived due to competition from implantable lenses and issues regarding Lasik procedures – recent trials show that men who had laparoscopic prostatectomies have a 40% greater risk of scarring than those who undergo open prostatectomy – and transurethral resection of the prostate is declining in favor of new drugs, laser treatments, and other technologies for prostatic ablation. [Learn More about Report A607]

Double-digit expansion is projected in many surgical procedures over the next five years.

Learn more with Medtech Insight market intelligence....

 

Surgical Procedure Volumes (SPV) Reports - Europe France, Germany, Italy, Spain, & The U.K.

Over the next five years, double-digit expansion is projected in many surgical procedures, including adrenalectomy, joint replacement, minimally-invasive spinal fixation, prostate disease/disorder management, and total disc replacement.

 

This new series of Medtech Insight reports includes the procedure volumes forecasts for open and laparoscopic surgery in France, Germany, Italy, Spain, and the U.K. from 2008 to 2013. Topics covered by these reports include an overview of European healthcare and regulatory policies, technological advancements in minimally-invasive surgery, and trends in healthcare funding and reimbursement… [Read More]

 

How to Simplify Tracking of Patients with Implanted Medical Devices and Improve FDA Compliance

Publisher's Spotlight: Introducing the Scantron TRaC II Digital Solution

No one knows better than device manufacturers just how difficult it can be to keep track of patients with implantable medical devices, much less reach them and their doctors in event of a recall. And yet that is exactly what the FDA’s medical device tracking guidelines require. They specify that manufacturers of certain devices establish and maintain a written standard operating procedure related to tracking devices, quality control, and audit procedures.

And when an FDA recall does occur, device manufacturers have just a few days to notify patients and doctors. The resulting frenzy can cost the unprepared business millions and may yield large FDA fines. Add the likelihood of bad press or the threat of lawsuits and compliance, executives face significant challenges.

Medical Device Market 2009: Interventional Cardiology

Elsevier Business Intelligence announces the publication of a new Special Report: Medical Device Market 2009 Interventional Cardiology. Who’s going beyond catheters and drug-eluting stents in this vibrant space. A special report previously published in IN VIVO: The Business & Medicine Report™  Read more...